Physician profile
Milan Patel
NPI 1952862773
$2,492.89
in general payments reported to CMS, 2019-2025
17 companies · $1,037 in 2025
The $1,037 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $39.92 · 2022: $571 · 2023: $525 · 2024: $320 · 2025: $1,037.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,614 · Education: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,613.51 |
| Education | $268.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $519.33 | 2021-2024 | Corevalve Evolut R, Endurant Iis, Heli-Fx Endoanchor System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $356.97 | 2025 | Lifevest |
| Abbott Laboratories | $268.60 | 2025 | Ensite |
| Astrazeneca Pharmaceuticals LP | $234.00 | 2022-2025 | Fasenra |
| Shockwave Medical, INC | $204.84 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Edwards Lifesciences Corporation | $182.56 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Novo Nordisk INC | $164.64 | 2022-2025 | Wegovy |
| Penumbra, INC. | $131.18 | 2025 | Indigo System |
| Amgen INC. | $116.10 | 2022 | |
| Cardiovascular Systems INC. | $84.47 | 2022-2023 | Diamondback Peripheral |
| Terumo Medical Corporation | $63.89 | 2022-2023 | Heartrail |
| Boston Scientific Corporation | $43.81 | 2023-2025 | Latitude Communicator Power Supply, Watchman Flx |
| Abiomed | $31.45 | 2024 | Impella |
| Phathom Pharmaceuticals, INC. | $28.68 | 2025 | Voquezna |
| Novartis Pharmaceuticals Corporation | $24.91 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $22.65 | 2025 | Camzyos |
| Pfizer INC. | $14.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Milan Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.